Cedars Sinai

Clinical care:at cedars-sinai, everything that was accomplished in 2022-23 supported one overarching goal: fulfilling its deep and abiding commitment to improving the lives of its patients and the health status of the communities it serves. Cedars-Sinai remains steadfast in its efforts to enhance quality of life through nurturing the health of the most vulnerable, eliminating disparities in treatments and patient outcomes, pioneering innovative Medical research, and training new generations of (see schedule o for continuation)(continued)scientists and clinicians. Cedars-Sinai's growth over the past year reflects these institutional values and is grounded in its dedication to its community.in fiscal year 2023, Cedars-Sinai Medical Center reported 298,624 inpatient days and 935,935 outpatient visits. Other volume measures include 45,439 inpatient admissions , and 85,300 emergency department visits. As one of the largest academic Medical centers in the western united states, Cedars-Sinai provides many highly specialized services that are not available at most other hospitals, and which require a significant infrastructure of technology and expert staffing. Cedars-Sinai was named to the honor roll for the eighth consecutive year and tied for #1 in California in u.s. news & world report's "best hospitals 2023-24" rankings-a reflection of its firm commitment to providing the highest-quality care to its patients. The smidt heart institute at Cedars-Sinai is home to one of the largest cardiothoracic transplant surgery programs in California and the nation. The smidt heart institute was also named a mitral valve repair reference Center, a recognition awarded to select u.s. Medical centers with a record of superior clinical outcomes.the Cedars-Sinai geriatric fracture program reduced the length of hospital stays for older adults with bone fractures and evaluated these patients for bone health and fall prevention. The program is helping people remain independent longer and offers a replicable model for other health systems. The Cedars-Sinai comprehensive transplant Center and smidt heart institute teams completed a record 616 solid organ transplants, an 11% increase from last year's high of 556. They also completed their first successful triple transplant-heart, liver and kidney.the guerin family congenital heart program earned accreditation from the adult congenital heart association, signifying an association with better patient outcomes and a clinical team that provides comprehensive expertise for complex congenital heart conditions requiring lifelong care.patients now have 24/7 virtual access to acute, chronic and preventive care experts and can make same-day appointments for primary care visits through a new healthcare app, Cedars-Sinai connect.

Training for physicians and other health professionals:in fiscal year 2023, Cedars-Sinai's net cost of providing these training programs was $106,628,733. Graduate school enrollment in Cedars-Sinai's master's in health delivery science, master's in magnetic resonance in medicine and phd programs continues to grow. Twenty-nine students graduated from these programs in fy23. (see schedule o for continuationcontinuedcedarssinais new diversity, equity and inclusion ambassadors program engaged residents from historically marginalized groups through mentorship, outreach and education. In fy23, more than 100 applicants vied for each available residency spot at cedars-sinai, and Cedars-Sinai interviewed the most diverse group of candidates ever.the women's guild simulation Center for advanced clinical skills celebrated its 10th anniversary. Over the past decade, the Center has helped 150,000 health professionals-and thousands of students-learn new techniques, improve existing practices and heighten team performance. More than 1,000 people train in the Center each month.the innovative diversity, equity and inclusion transition to practice program at Cedars-Sinai supported promising nurses who have experience, but not in an inpatient setting. The program has provided mentorship to more than 30 nurses to date, advancing them to new levels of expertise while also helping to address a national nursing shortage.eighty-four percent of neurosurgery residency applicants in the u.s. Applied for one of two spots available at cedars-sinai, while 502 applicants sought one of its five neurology residency slots.cedars-sinai faculty provided extensive, highly competitive Medical training programs for physicians and health professionals in 88 specialty and subspecialty areas. New programs in pediatrics and neurocritical care were approved by the accreditation council for graduate Medical education (acgme).

Research:in fiscal year 2023, Cedars-Sinai's total cost of research was $136,890,994 , including 386 national institutes of health grants and other grants totaling $180,898,056 . With a five-year $11.2 million national cancer institute grant, Cedars-Sinai cancer investigators intensified their research on how biological differences between men and women affect bladder cancer, (see schedule o for continuation)(continued)with the goal of shaping therapies to improve patient outcomes. Neurosurgeons at Cedars-Sinai identified an immune cell subtype in the retina that is linked to changes caused by alzheimer's disease-and potentially numerous eye disorders.a study by investigators in the Cedars-Sinai department of obstetrics and gynecology found that black and latina patients are significantly less likely than white patients to undergo minimally invasive surgery for uterine fibroids. Further research is ongoing to identify pathways for all women to have equal access to high-quality, evidence-based care.new analyses from the smidt heart institute found that deaths from heart attacks rose during covid-19 surges-most significantly for those who are between 25 and 44 years old-reversing a pre-pandemic trend of declining deaths due to cardiac arrests.a blood test discovered by Cedars-Sinai investigators can now identify pregnant women at risk of developing the life-threatening blood pressure disorder preeclampsia. The test has been approved by the u.s. food and drug administration.